Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer

Abroad (travel likely)RecruitingPHASE2, PHASE3

Conditions

Renal Pelvis and Ureter Urothelial Carcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Kingman Regional Medical Center, Kingman, Arizona, United States

    Contact: Study coordinator (Site Public Contact) · research@sncrf.org · 702-384-0013
    Contact: Principal Investigator (John A. Ellerton)
  • Mercy Hospital Fort Smith, Fort Smith, Arkansas, United States

  • University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States

  • Sutter Auburn Faith Hospital, Auburn, California, United States

  • Alta Bates Summit Medical Center-Herrick Campus, Berkeley, California, United States

  • City of Hope Comprehensive Cancer Center, Duarte, California, United States

    Contact: Study coordinator (Site Public Contact) · becomingapatient@coh.org · 800-826-4673
    Contact: Principal Investigator (Abhishek Tripathi)
  • Palo Alto Medical Foundation-Fremont, Fremont, California, United States

  • UC San Diego Moores Cancer Center, La Jolla, California, United States

    Contact: Study coordinator (Site Public Contact) · cancercto@ucsd.edu · 858-822-5354
    Contact: Principal Investigator (Aditya Bagrodia)
  • Memorial Medical Center, Modesto, California, United States

  • Palo Alto Medical Foundation-Camino Division, Mountain View, California, United States

  • Palo Alto Medical Foundation Health Care, Palo Alto, California, United States

  • Stanford Cancer Institute Palo Alto, Palo Alto, California, United States

    Contact: Study coordinator (Site Public Contact) · ccto-office@stanford.edu · 650-498-7061
    Contact: Principal Investigator (Ali R. Khaki)
  • Sutter Roseville Medical Center, Roseville, California, United States

  • Sutter Medical Center Sacramento, Sacramento, California, United States

  • UC San Diego Medical Center - Hillcrest, San Diego, California, United States

    Contact: Study coordinator (Site Public Contact) · rhabbaba@health.ucsd.edu
    Contact: Principal Investigator (Aditya Bagrodia)
  • California Pacific Medical Center-Pacific Campus, San Francisco, California, United States

  • Palo Alto Medical Foundation-Santa Cruz, Santa Cruz, California, United States

  • Sutter Pacific Medical Foundation, Santa Rosa, California, United States

  • Palo Alto Medical Foundation-Sunnyvale, Sunnyvale, California, United States

  • Sutter Solano Medical Center/Cancer Center, Vallejo, California, United States

  • UCHealth University of Colorado Hospital, Aurora, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · 720-848-0650
    Contact: Principal Investigator (Elizabeth R. Kessler)
  • UCHealth - Cherry Creek, Denver, Colorado, United States

  • Poudre Valley Hospital, Fort Collins, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · 970-297-6150
    Contact: Principal Investigator (Elizabeth R. Kessler)
  • Cancer Care and Hematology-Fort Collins, Fort Collins, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · ecog.rss@jimmy.harvard.edu
    Contact: Principal Investigator (Elizabeth R. Kessler)
  • UCHealth Greeley Hospital, Greeley, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · ecog.rss@jimmy.harvard.edu
    Contact: Principal Investigator (Elizabeth R. Kessler)
  • UCHealth Highlands Ranch Hospital, Highlands Ranch, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · 720-848-0650
    Contact: Principal Investigator (Elizabeth R. Kessler)
  • UCHealth Lone Tree Health Center, Lone Tree, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · ecog.rss@jimmy.harvard.edu
    Contact: Principal Investigator (Elizabeth R. Kessler)
  • Medical Center of the Rockies, Loveland, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · 970-203-7083
    Contact: Principal Investigator (Elizabeth R. Kessler)
  • MedStar Washington Hospital Center, Washington D.C., District of Columbia, United States

    Contact: Study coordinator (Site Public Contact) · 202-877-8839
    Contact: Principal Investigator (Suthee Rapisuwon)
  • Sibley Memorial Hospital, Washington D.C., District of Columbia, United States

    Contact: Study coordinator (Site Public Contact) · jquiver1@jhmi.edu · 202-243-2373
    Contact: Principal Investigator (Jean H. Hoffman-Censits)
  • Mayo Clinic in Florida, Jacksonville, Florida, United States

  • Emory University Hospital Midtown, Atlanta, Georgia, United States

    Contact: Study coordinator (Site Public Contact) · 888-946-7447
    Contact: Principal Investigator (Jacqueline T. Brown)
  • Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States

    Contact: Study coordinator (Site Public Contact) · 404-778-1868
    Contact: Principal Investigator (Jacqueline T. Brown)
  • Emory Saint Joseph's Hospital, Atlanta, Georgia, United States

    Contact: Study coordinator (Site Public Contact) · 404-851-7115
    Contact: Principal Investigator (Jacqueline T. Brown)
  • Emory Decatur Hospital, Decatur, Georgia, United States

    Contact: Study coordinator (Site Public Contact) · clinicaltrialsoncology@dekalbmedical.org · 440-778-1868
    Contact: Principal Investigator (Jacqueline T. Brown)
  • Saint Alphonsus Cancer Care Center-Nampa, Nampa, Idaho, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (Elie G. Dib)
  • OSF Saint Anthony's Health Center, Alton, Illinois, United States

  • Advocate Good Shepherd Hospital, Barrington, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 847-842-4847
    Contact: Principal Investigator (Thomas J. Saphner)
  • Illinois CancerCare-Bloomington, Bloomington, Illinois, United States

  • Loyola Center for Health at Burr Ridge, Burr Ridge, Illinois, United States

  • Illinois CancerCare-Canton, Canton, Illinois, United States

  • Memorial Hospital of Carbondale, Carbondale, Illinois, United States

  • SIH Cancer Institute, Carterville, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · clinical.research@sih.net · 618-985-3333
    Contact: Principal Investigator (Bryan A. Faller)
  • Illinois CancerCare-Carthage, Carthage, Illinois, United States

  • Centralia Oncology Clinic, Centralia, Illinois, United States

  • Advocate Illinois Masonic Medical Center, Chicago, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 773-296-5360
    Contact: Principal Investigator (Thomas J. Saphner)
  • AMG Crystal Lake - Oncology, Crystal Lake, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · advocateresearch@advocate.com · 630-929-6129
    Contact: Principal Investigator (Thomas J. Saphner)
  • Carle at The Riverfront, Danville, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Research@Carle.com · 800-446-5532
    Contact: Principal Investigator (Prem Sobti)
  • Cancer Care Specialists of Illinois - Decatur, Decatur, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · morganthaler.jodi@mhsil.com · 217-876-4762
    Contact: Principal Investigator (Bryan A. Faller)
  • Decatur Memorial Hospital, Decatur, Illinois, United States

  • Illinois CancerCare-Dixon, Dixon, Illinois, United States

  • Advocate Good Samaritan Hospital, Downers Grove, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Barbara.barhamand@advocatehealth.com · 630-275-1270
    Contact: Principal Investigator (Thomas J. Saphner)
  • Carle Physician Group-Effingham, Effingham, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Research@carle.com · 800-446-5532
    Contact: Principal Investigator (Prem Sobti)
  • Crossroads Cancer Center, Effingham, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · morganthaler.jodi@mhsil.com · 217-876-4762
    Contact: Principal Investigator (Bryan A. Faller)
  • Advocate Sherman Hospital, Elgin, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 847-429-2907
    Contact: Principal Investigator (Thomas J. Saphner)
  • Illinois CancerCare-Eureka, Eureka, Illinois, United States

  • Illinois CancerCare-Galesburg, Galesburg, Illinois, United States

  • Western Illinois Cancer Treatment Center, Galesburg, Illinois, United States

  • Advocate South Suburban Hospital, Hazel Crest, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 708-799-9995
    Contact: Principal Investigator (Thomas J. Saphner)
  • Loyola Medicine Homer Glen, Homer Glen, Illinois, United States

  • Illinois CancerCare-Kewanee Clinic, Kewanee, Illinois, United States

  • AMG Libertyville - Oncology, Libertyville, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · advocateresearch@advocatehealth.com · 630-929-6129
    Contact: Principal Investigator (Thomas J. Saphner)
  • Illinois CancerCare-Macomb, Macomb, Illinois, United States

  • Carle Physician Group-Mattoon/Charleston, Mattoon, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Research@carle.com · 800-446-5532
    Contact: Principal Investigator (Prem Sobti)
  • Loyola University Medical Center, Maywood, Illinois, United States

  • Marjorie Weinberg Cancer Center at Loyola-Gottlieb, Melrose Park, Illinois, United States

  • SSM Health Good Samaritan, Mount Vernon, Illinois, United States

  • Cancer Care Center of O'Fallon, O'Fallon, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · morganthaler.jodi@mhsil.com · 217-876-4762
    Contact: Principal Investigator (Bryan A. Faller)
  • Advocate Christ Medical Center, Oak Lawn, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 800-323-8622
    Contact: Principal Investigator (Thomas J. Saphner)
  • Illinois CancerCare-Ottawa Clinic, Ottawa, Illinois, United States

  • Advocate Lutheran General Hospital, Park Ridge, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 847-384-3621
    Contact: Principal Investigator (Thomas J. Saphner)
  • Illinois CancerCare-Pekin, Pekin, Illinois, United States

  • Illinois CancerCare-Peoria, Peoria, Illinois, United States

  • Methodist Medical Center of Illinois, Peoria, Illinois, United States

  • Illinois CancerCare-Peru, Peru, Illinois, United States

  • Valley Radiation Oncology, Peru, Illinois, United States

  • Illinois CancerCare-Princeton, Princeton, Illinois, United States

  • Southern Illinois University School of Medicine, Springfield, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 217-545-7929
    Contact: Principal Investigator (Bryan A. Faller)
  • Springfield Clinic, Springfield, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 800-444-7541
    Contact: Principal Investigator (Bryan A. Faller)
  • Springfield Memorial Hospital, Springfield, Illinois, United States

  • Carle Cancer Center, Urbana, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Research@carle.com · 800-446-5532
    Contact: Principal Investigator (Prem Sobti)
  • Illinois CancerCare - Washington, Washington, Illinois, United States

  • Reid Health, Richmond, Indiana, United States

  • Mary Greeley Medical Center, Ames, Iowa, United States

  • McFarland Clinic - Ames, Ames, Iowa, United States

  • University of Iowa Healthcare Cancer Services Quad Cities, Bettendorf, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · katherine-daprile@uiowa.edu · 563-355-7733
    Contact: Principal Investigator (Fernando Maciel Barbosa)
  • McFarland Clinic - Boone, Boone, Iowa, United States

  • McFarland Clinic - Trinity Cancer Center, Fort Dodge, Iowa, United States

  • University of Iowa/Holden Comprehensive Cancer Center, Iowa City, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 800-237-1225
    Contact: Principal Investigator (Fernando Maciel Barbosa)
  • McFarland Clinic - Jefferson, Jefferson, Iowa, United States

  • McFarland Clinic - Marshalltown, Marshalltown, Iowa, United States

  • Central Care Cancer Center - Garden City, Garden City, Kansas, United States

  • Central Care Cancer Center - Great Bend, Great Bend, Kansas, United States

  • University of Kentucky/Markey Cancer Center, Lexington, Kentucky, United States

    Contact: Study coordinator (Site Public Contact) · 859-257-3379
    Contact: Principal Investigator (Patrick J. Hensley)
  • Mary Bird Perkins Cancer Center, Baton Rouge, Louisiana, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@marybird.com · 225-215-1353
    Contact: Principal Investigator (Victor T. Lin)
  • Mary Bird Perkins Cancer Center - Metairie, Metairie, Louisiana, United States

    Contact: Study coordinator (Site Public Contact) · 504-584-6990
    Contact: Principal Investigator (Victor T. Lin)
  • East Jefferson General Hospital, Metairie, Louisiana, United States

    Contact: Study coordinator (Site Public Contact) · emede1@lsuhsc.edu · 504-210-3539
    Contact: Principal Investigator (Rajasree P. Chowdry)
  • LSU Healthcare Network / Metairie Multi-Specialty Clinic, Metairie, Louisiana, United States

    Contact: Study coordinator (Site Public Contact) · emede1@lsuhsc.edu · 504-210-3539
    Contact: Principal Investigator (Rajasree P. Chowdry)
  • University Medical Center New Orleans, New Orleans, Louisiana, United States

    Contact: Study coordinator (Site Public Contact) · emede1@lsuhsc.edu · 504-210-3539
    Contact: Principal Investigator (Rajasree P. Chowdry)
  • Harold Alfond Center for Cancer Care, Augusta, Maine, United States

    Contact: Study coordinator (Site Public Contact) · 207-626-4855
    Contact: Principal Investigator (Erin Adler)
  • MaineHealth Maine Medical Center - Biddeford, Biddeford, Maine, United States

  • MaineHealth Cancer Care and IV Therapy - Sanford, Sanford, Maine, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@mainehealth.org · 207-396-8670
    Contact: Principal Investigator (Erin Adler)
  • MaineHealth Cancer Care Center of York County, Sanford, Maine, United States

    Contact: Study coordinator (Site Public Contact) · 207-459-1600
    Contact: Principal Investigator (Erin Adler)
  • MaineHealth Maine Medical Center- Scarborough, Scarborough, Maine, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@mainehealth.org · 207-396-8670
    Contact: Principal Investigator (Erin Adler)
  • MaineHealth Cancer Care and IV Therapy - South Portland, South Portland, Maine, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@mainehealth.org · 207-396-8670
    Contact: Principal Investigator (Erin Adler)
  • Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland, United States

    Contact: Study coordinator (Site Public Contact) · jhcccro@jhmi.edu · 410-955-8804
    Contact: Principal Investigator (Jean H. Hoffman-Censits)
  • UMass Memorial Medical Center - University Campus, Worcester, Massachusetts, United States

    Contact: Study coordinator (Site Public Contact) · cancer.research@umassmed.edu · 508-856-3216
    Contact: Principal Investigator (Kriti Mittal)
  • Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Elie G. Dib)
  • Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Elie G. Dib)
  • Trinity Health Medical Center - Brighton, Brighton, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Elie G. Dib)
  • Trinity Health IHA Medical Group Hematology Oncology - Canton, Canton, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Elie G. Dib)
  • Trinity Health Medical Center - Canton, Canton, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Elie G. Dib)
  • Chelsea Hospital, Chelsea, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Elie G. Dib)
  • Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Elie G. Dib)
  • Hematology Oncology Consultants-Clarkston, Clarkston, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Elie G. Dib)
  • Newland Medical Associates-Clarkston, Clarkston, Michigan, United States

  • Cancer Hematology Centers - Flint, Flint, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · wstrong@ghci.org · 810-762-8038
    Contact: Principal Investigator (Elie G. Dib)
  • Genesee Hematology Oncology PC, Flint, Michigan, United States

  • Genesys Hurley Cancer Institute, Flint, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · wstrong@ghci.org · 810-762-8038
    Contact: Principal Investigator (Elie G. Dib)
  • Hurley Medical Center, Flint, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · wstrong@ghci.org · 810-762-8038
    Contact: Principal Investigator (Elie G. Dib)
  • Hope Cancer Clinic, Livonia, Michigan, United States

  • Trinity Health Saint Mary Mercy Livonia Hospital, Livonia, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Elie G. Dib)
  • Henry Ford Saint John Hospital - Macomb Medical, Macomb, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · kforman1@hfhs.org · 313-343-3166
    Contact: Principal Investigator (Elie G. Dib)
  • Michigan Healthcare Professionals Pontiac, Pontiac, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · Emily.Crofts@trinity-health.org · 248-858-6215
    Contact: Principal Investigator (Elie G. Dib)
  • Newland Medical Associates-Pontiac, Pontiac, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Elie G. Dib)
  • Trinity Health Saint Joseph Mercy Oakland Hospital, Pontiac, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Elie G. Dib)
  • MyMichigan Medical Center Saginaw, Saginaw, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Elie G. Dib)
  • Oncology Hematology Associates of Saginaw Valley PC, Saginaw, Michigan, United States

  • MyMichigan Medical Center Tawas, Tawas City, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Elie G. Dib)
  • Saint Mary's Oncology/Hematology Associates of West Branch, West Branch, Michigan, United States

  • Huron Gastroenterology PC, Ypsilanti, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Elie G. Dib)
  • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Elie G. Dib)
  • Fairview Ridges Hospital, Burnsville, Minnesota, United States

  • Minnesota Oncology - Burnsville, Burnsville, Minnesota, United States

  • Cambridge Medical Center, Cambridge, Minnesota, United States

  • Mercy Hospital, Coon Rapids, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (David M. King)
  • Fairview Southdale Hospital, Edina, Minnesota, United States

  • Unity Hospital, Fridley, Minnesota, United States

  • Fairview Clinics and Surgery Center Maple Grove, Maple Grove, Minnesota, United States

  • Minnesota Oncology Hematology PA-Maplewood, Maplewood, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (David M. King)
  • Saint John's Hospital - Healtheast, Maplewood, Minnesota, United States

  • Abbott-Northwestern Hospital, Minneapolis, Minnesota, United States

  • Hennepin County Medical Center, Minneapolis, Minnesota, United States

  • Health Partners Inc, Minneapolis, Minnesota, United States

  • Monticello Cancer Center, Monticello, Minnesota, United States

  • New Ulm Medical Center, New Ulm, Minnesota, United States

  • Fairview Northland Medical Center, Princeton, Minnesota, United States

  • North Memorial Medical Health Center, Robbinsdale, Minnesota, United States

  • Mayo Clinic in Rochester, Rochester, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · 855-776-0015
    Contact: Principal Investigator (Lance C. Pagliaro)
  • Park Nicollet Clinic - Saint Louis Park, Saint Louis Park, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (David M. King)
  • Regions Hospital, Saint Paul, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (David M. King)
  • United Hospital, Saint Paul, Minnesota, United States

  • Saint Francis Regional Medical Center, Shakopee, Minnesota, United States

  • Lakeview Hospital, Stillwater, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (David M. King)
  • Ridgeview Medical Center, Waconia, Minnesota, United States

  • Rice Memorial Hospital, Willmar, Minnesota, United States

  • Minnesota Oncology Hematology PA-Woodbury, Woodbury, Minnesota, United States

  • Fairview Lakes Medical Center, Wyoming, Minnesota, United States

  • Mercy Oncology and Hematology - Clayton-Clarkson, Ballwin, Missouri, United States

  • Central Care Cancer Center - Bolivar, Bolivar, Missouri, United States

  • Mercy Cancer Center - Cape Girardeau, Cape Girardeau, Missouri, United States

  • Saint Francis Medical Center, Cape Girardeau, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · sfmc@sfmc.net · 573-334-2230
    Contact: Principal Investigator (Bryan A. Faller)
  • Parkland Health Center - Farmington, Farmington, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · 314-996-5569
    Contact: Principal Investigator (Bryan A. Faller)
  • MU Health Care Goldschmidt Cancer Center, Jefferson City, Missouri, United States

  • Freeman Health System, Joplin, Missouri, United States

  • Mercy Hospital Joplin, Joplin, Missouri, United States

  • Mercy Clinic-Rolla-Cancer and Hematology, Rolla, Missouri, United States

  • Phelps Health Delbert Day Cancer Institute, Rolla, Missouri, United States

  • Heartland Regional Medical Center, Saint Joseph, Missouri, United States

  • Sainte Genevieve County Memorial Hospital, Sainte Genevieve, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · 314-996-5569
    Contact: Principal Investigator (Bryan A. Faller)
  • Mercy Hospital Springfield, Springfield, Missouri, United States

  • CoxHealth South Hospital, Springfield, Missouri, United States

  • Mercy Infusion Center - Chippewa, St Louis, Missouri, United States

  • Mercy Hospital South, St Louis, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · Danielle.Werle@mercy.net · 314-525-6042
    Contact: Principal Investigator (Jay W. Carlson)
  • Missouri Baptist Medical Center, St Louis, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · 314-996-5569
    Contact: Principal Investigator (Bryan A. Faller)
  • Mercy Hospital Saint Louis, St Louis, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · 314-251-7066
    Contact: Principal Investigator (Jay W. Carlson)
  • Missouri Baptist Sullivan Hospital, Sullivan, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · 314-996-5569
    Contact: Principal Investigator (Bryan A. Faller)
  • BJC Outpatient Center at Sunset Hills, Sunset Hills, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · 314-996-5569
    Contact: Principal Investigator (Bryan A. Faller)
  • Mercy Hospital Washington, Washington, Missouri, United States

  • OptumCare Cancer Care at Charleston, Las Vegas, Nevada, United States

    Contact: Study coordinator (Site Public Contact) · research@sncrf.org · 702-384-0013
    Contact: Principal Investigator (John A. Ellerton)
  • OptumCare Cancer Care at Fort Apache, Las Vegas, Nevada, United States

    Contact: Study coordinator (Site Public Contact) · research@sncrf.org · 702-384-0013
    Contact: Principal Investigator (John A. Ellerton)
  • Hackensack University Medical Center, Hackensack, New Jersey, United States

  • Saint Barnabas Medical Center, Livingston, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · joanne.loeb@rwjbh.org · 973-322-2934
    Contact: Principal Investigator (Saum B. Ghodoussipour)
  • Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · 732-235-7356
    Contact: Principal Investigator (Saum B. Ghodoussipour)
  • Community Medical Center, Toms River, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · Lennette.Gonzales@rwjbh.org · 732-557-8294
    Contact: Principal Investigator (Saum B. Ghodoussipour)
  • University of New Mexico Cancer Center, Albuquerque, New Mexico, United States

    Contact: Study coordinator (Site Public Contact) · HSC-ClinicalTrialInfo@salud.unm.edu · 505-925-0348
    Contact: Principal Investigator (Amy C. Tarnower)
  • Roswell Park Cancer Institute, Buffalo, New York, United States

  • Southeastern Medical Oncology Center-Clinton, Clinton, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · jfields@cancersmoc.com · 919-587-9084
    Contact: Principal Investigator (Samer S. Kasbari)
  • Southeastern Medical Oncology Center-Goldsboro, Goldsboro, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · jfields@cancersmoc.com · 919-587-9084
    Contact: Principal Investigator (Samer S. Kasbari)
  • Southeastern Medical Oncology Center-Jacksonville, Jacksonville, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · jfields@cancersmoc.com · 910-587-9084
    Contact: Principal Investigator (Samer S. Kasbari)
  • Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States

  • Dayton Physicians LLC-Miami Valley South, Centerville, Ohio, United States

  • Miami Valley Hospital South, Centerville, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@daytonncorp.org · 937-528-2900
    Contact: Principal Investigator (Tarek M. Sabagh)
  • Miami Valley Hospital, Dayton, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@daytonncorp.org · 937-528-2900
    Contact: Principal Investigator (Tarek M. Sabagh)
  • Premier Blood and Cancer Center, Dayton, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · 937-276-8320
    Contact: Principal Investigator (Tarek M. Sabagh)
  • Dayton Physician LLC - Englewood, Dayton, Ohio, United States

  • Miami Valley Hospital North, Dayton, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@daytonncorp.org · 937-528-2900
    Contact: Principal Investigator (Tarek M. Sabagh)
  • Armes Family Cancer Center, Findlay, Ohio, United States

  • Atrium Medical Center-Middletown Regional Hospital, Franklin, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@daytonncorp.org · 937-528-2900
    Contact: Principal Investigator (Tarek M. Sabagh)
  • Dayton Physicians LLC-Atrium, Franklin, Ohio, United States

  • Miami Valley Cancer Care and Infusion, Greenville, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · 937-569-7515
    Contact: Principal Investigator (Tarek M. Sabagh)
  • Greater Dayton Cancer Center, Kettering, Ohio, United States

  • Kettering Medical Center, Kettering, Ohio, United States

  • Springfield Regional Cancer Center, Springfield, Ohio, United States

  • ProMedica Flower Hospital, Sylvania, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · PCIOncResearch@promedica.org · 419-824-1842
    Contact: Principal Investigator (Jeffrey H. Muler)
  • Upper Valley Medical Center, Troy, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@daytonncorp.org · 937-528-2900
    Contact: Principal Investigator (Tarek M. Sabagh)
  • Cancer Centers of Southwest Oklahoma Research, Lawton, Oklahoma, United States

    Contact: Study coordinator (Site Public Contact) · 877-231-4440
    Contact: Principal Investigator (Adanma Anji Ayanambakkam Attanathi)
  • University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States

    Contact: Study coordinator (Site Public Contact) · ou-clinical-trials@ouhsc.edu · 405-271-8777
    Contact: Principal Investigator (Adanma Anji Ayanambakkam Attanathi)
  • Mercy Hospital Oklahoma City, Oklahoma City, Oklahoma, United States

  • UPMC Hillman Cancer Center Erie, Erie, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · ClinicalResearchServices@upmc.edu · 412-864-7716
    Contact: Principal Investigator (Leonard J. Appleman)
  • UPMC Cancer Centers - Arnold Palmer Pavilion, Greensburg, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 724-838-1900
    Contact: Principal Investigator (Leonard J. Appleman)
  • Penn State Milton S Hershey Medical Center, Hershey, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · CTO@hmc.psu.edu · 717-531-3779
    Contact: Principal Investigator (Monika Joshi)
  • UPMC Hillman Cancer Center - Monroeville, Monroeville, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · ClinicalResearchServices@upmc.edu · 412-864-7716
    Contact: Principal Investigator (Leonard J. Appleman)
  • University of Pennsylvania/Abramson Cancer Center, Philadelphia, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · PMCancerResearch@pennmedicine.upenn.edu · 215-349-8245
    Contact: Principal Investigator (Ronac Mamtani)
  • Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · ONCTrialNow@jefferson.edu · 215-600-9151
    Contact: Principal Investigator (William J. Tester)
  • University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 412-647-8073
    Contact: Principal Investigator (Leonard J. Appleman)
  • UPMC-Passavant Hospital, Pittsburgh, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 412-367-6454
    Contact: Principal Investigator (Leonard J. Appleman)
  • UPMC-Saint Clair Hospital Cancer Center, Pittsburgh, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 412-502-3920
    Contact: Principal Investigator (Leonard J. Appleman)
  • UPMC Cancer Center-Washington, Washington, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · ecog.rss@jimmy.harvard.edu
    Contact: Principal Investigator (Leonard J. Appleman)
  • Reading Hospital, West Reading, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 610-988-9323
    Contact: Principal Investigator (Terrence P. Cescon)
  • Medical University of South Carolina, Charleston, South Carolina, United States

  • Parkland Memorial Hospital, Dallas, Texas, United States

    Contact: Study coordinator (Site Public Contact) · canceranswerline@UTSouthwestern.edu · 214-590-5582
    Contact: Principal Investigator (Vitaly Margulis)
  • UT Southwestern Simmons Cancer Center - RedBird, Dallas, Texas, United States

  • UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas, United States

    Contact: Study coordinator (Site Public Contact) · canceranswerline@UTSouthwestern.edu · 214-648-7097
    Contact: Principal Investigator (Vitaly Margulis)
  • UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth, Texas, United States

    Contact: Study coordinator (Site Public Contact) · canceranswerline@UTSouthwestern.edu · 214-648-7097
    Contact: Principal Investigator (Vitaly Margulis)
  • UT Southwestern Clinical Center at Richardson/Plano, Richardson, Texas, United States

    Contact: Study coordinator (Site Public Contact) · Suzanne.cole@utsouthwestern.edu · 972-669-7044
    Contact: Principal Investigator (Vitaly Margulis)
  • Fred Hutchinson Cancer Center, Seattle, Washington, United States

    Contact: Study coordinator (Site Public Contact) · 800-804-8824
    Contact: Principal Investigator (Petros Grivas)
  • University of Washington Medical Center - Montlake, Seattle, Washington, United States

    Contact: Study coordinator (Site Public Contact) · 800-804-8824
    Contact: Principal Investigator (Petros Grivas)
  • West Virginia University Charleston Division, Charleston, West Virginia, United States

    Contact: Study coordinator (Site Public Contact) · 304-388-9944
    Contact: Principal Investigator (Kok Hoe Chan)
  • ThedaCare Regional Cancer Center, Appleton, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ResearchDept@thedacare.org · 920-364-3604
    Contact: Principal Investigator (Matthias Weiss)
  • Aurora Cancer Care-Southern Lakes VLCC, Burlington, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Thomas J. Saphner)
  • Marshfield Medical Center-EC Cancer Center, Eau Claire, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · oncology.clinical.trials@marshfieldresearch.org · 800-782-8581
    Contact: Principal Investigator (Seth O. Fagbemi)
  • Aurora Health Care Germantown Health Center, Germantown, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Thomas J. Saphner)
  • Aurora Cancer Care-Grafton, Grafton, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Thomas J. Saphner)
  • Aurora BayCare Medical Center, Green Bay, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Thomas J. Saphner)
  • Aurora Cancer Care-Kenosha South, Kenosha, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Thomas J. Saphner)
  • Aurora Bay Area Medical Group-Marinette, Marinette, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Thomas J. Saphner)
  • Marshfield Medical Center-Marshfield, Marshfield, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · oncology.clinical.trials@marshfieldresearch.org · 800-782-8581
    Contact: Principal Investigator (Seth O. Fagbemi)
  • Aurora Cancer Care-Milwaukee, Milwaukee, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Thomas J. Saphner)
  • Aurora Saint Luke's Medical Center, Milwaukee, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Thomas J. Saphner)
  • Aurora Sinai Medical Center, Milwaukee, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Thomas J. Saphner)
  • Marshfield Medical Center - Minocqua, Minocqua, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · oncology.clinical.trials@marshfieldresearch.org · 800-782-8581
    Contact: Principal Investigator (Seth O. Fagbemi)
  • ProHealth D N Greenwald Center, Mukwonago, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · research.institute@phci.org
    Contact: Principal Investigator (Timothy R. Wassenaar)
  • Cancer Center of Western Wisconsin, New Richmond, Wisconsin, United States

  • ProHealth Oconomowoc Memorial Hospital, Oconomowoc, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · 262-928-7878
    Contact: Principal Investigator (Timothy R. Wassenaar)
  • Vince Lombardi Cancer Clinic - Oshkosh, Oshkosh, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Thomas J. Saphner)
  • Aurora Cancer Care-Racine, Racine, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Thomas J. Saphner)
  • Marshfield Medical Center-Rice Lake, Rice Lake, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · oncology.clinical.trials@marshfieldresearch.org · 800-782-8581
    Contact: Principal Investigator (Seth O. Fagbemi)
  • Vince Lombardi Cancer Clinic-Sheboygan, Sheboygan, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Thomas J. Saphner)
  • Marshfield Medical Center-River Region at Stevens Point, Stevens Point, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · oncology.clinical.trials@marshfieldresearch.org · 800-782-8581
    Contact: Principal Investigator (Seth O. Fagbemi)
  • Aurora Medical Center in Summit, Summit, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Thomas J. Saphner)
  • Vince Lombardi Cancer Clinic-Two Rivers, Two Rivers, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Thomas J. Saphner)
  • ProHealth Waukesha Memorial Hospital, Waukesha, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · 262-928-7632
    Contact: Principal Investigator (Timothy R. Wassenaar)
  • UW Cancer Center at ProHealth Care, Waukesha, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · Chanda.miller@phci.org · 262-928-5539
    Contact: Principal Investigator (Timothy R. Wassenaar)
  • ThedaCare Cancer Care - Waupaca, Waupaca, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ResearchDept@thedacare.org · 920-364-3605
    Contact: Principal Investigator (Matthias Weiss)
  • Aurora Cancer Care-Milwaukee West, Wauwatosa, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Thomas J. Saphner)
  • Aurora West Allis Medical Center, West Allis, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Thomas J. Saphner)
  • Marshfield Medical Center - Weston, Weston, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · oncology.clinical.trials@marshfieldresearch.org · 800-782-8581
    Contact: Principal Investigator (Seth O. Fagbemi)
Study leads
  • Jean H Hoffman-Censits

    Principal Investigator

    ECOG-ACRIN Cancer Research Group